熱門資訊> 正文
Virpax重新遵守纳斯达克最低出价
2024-07-24 20:59
- Virpax Pharmaceuticals (NASDAQ:VRPX) has received formal notice from the Listing Qualifications staff of The Nasdaq indicating that Virpax has regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule.
- To regain compliance with the Rule, the Co.’s common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, which was achieved on July 19, 2024.
More on Virpax Pharmaceuticals
- Virpax announces $2.5M loan financing, additional pact with investor
- Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals
- Historical earnings data for Virpax Pharmaceuticals
- Financial information for Virpax Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
